Interestingly, inhibition of glutaminolysis by the glutaminase inhibitor CB-839 sensitized ovarian cancer cells to PP242 treatment [43], the same mTOR inhibitor which also blocked C. parvum infection in this study. Here, GLS is linked to ovarian carcinoma.